Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RinGlar vs Lantus PK/PD in Type 1 Diabetes
NCT04101383Phase 1Completed
- Sponsor
- Geropharm
- Start
- Oct 2017
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin glargine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Geropharm. Primary endpoints: Area Under the Curve of Glucose Infusion Rate from time 0 to t and Area Under the Concentration-Time Curve from time 0 to t. Started Oct 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04101383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101383.